ENDRA Life Sciences (NDRA) Income from Continuing Operations (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Income from Continuing Operations of 1311433.0 for Q1 2026, down 26.55% year-over-year from 1785377.24 in Q1 2025, and up 58.62% quarter-over-quarter from 3169209.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Income from Continuing Operations (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Income from Continuing Operations for 11 consecutive years, with 1311433.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 26.55% year-over-year to 1311433.0; the TTM figure through Mar 2026 stood at 7302513.0 (up 18.37% YoY), while the FY2025 annual figure was 5551610.0, up 48.05% from the prior year.
- Income from Continuing Operations rose to 1311433.0 in Q1 2026 per NDRA's latest filing, from 3169209.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 1036330.0 in Q1 2025 and bottomed at 3591067.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 2486096.0 across 5 years, with a median of 2775700.0 in 2024.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations sank 127.92% — and 2025, when it jumped 62.66%.
- ENDRA Life Sciences' Income from Continuing Operations stood at 3289596.0 in 2022, then soared by 55.63% to 1459536.0 in 2023, then tumbled by 127.92% to 3326504.0 in 2024, then climbed by 4.73% to 3169209.0 in 2025, then jumped by 58.62% to 1311433.0 in 2026.
- Business Quant data shows NDRA's Income from Continuing Operations at 1311433.0 in Q1 2026, 3169209.0 in Q4 2025, and 1595959.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 159,944.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 159,944.00 |
| Mar 31, 2026 | -1.31 Mn |
| Dec 31, 2025 | -3.17 Mn |
| Sep 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Dec 31, 2024 | -1.73 Mn |
| Sep 30, 2024 | -2.35 Mn |
| Jun 30, 2024 | -2.23 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | -1.46 Mn |
| Sep 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -2.56 Mn |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -3.29 Mn |
| Sep 30, 2022 | -3.44 Mn |
| Jun 30, 2022 | -3.59 Mn |
| Mar 31, 2022 | -2.86 Mn |
| Dec 31, 2021 | -3.10 Mn |
| Sep 30, 2021 | -2.66 Mn |